Extracellular signal-regulated kinases
Protein family involved in cellular signal transduction
Extracellular signal-regulated kinases (ERKs) are a group of protein-serine/threonine kinases that are activated by a variety of extracellular signals. They are part of the mitogen-activated protein kinase (MAPK) pathway, which plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival.
Structure and Function
ERKs are typically activated through a phosphorylation cascade initiated by the binding of growth factors, hormones, or other signaling molecules to cell surface receptors. This activation leads to the phosphorylation of ERKs by upstream kinases, such as MAP kinase kinase (MEK). Once activated, ERKs translocate to the cell nucleus, where they phosphorylate various nuclear targets, including transcription factors, thereby influencing gene expression.
Types of ERKs
The ERK family consists of several isoforms, with ERK1 and ERK2 being the most studied. These isoforms share significant sequence homology and are often referred to collectively as ERK1/2. Other members of the ERK family include ERK3, ERK4, ERK5, and ERK7, each with distinct regulatory mechanisms and functions.
Role in Disease
Dysregulation of ERK signaling has been implicated in various diseases, particularly cancer. Overactivation of ERK pathways can lead to uncontrolled cell growth and proliferation, contributing to tumorigenesis. Inhibitors targeting components of the ERK pathway are being developed as potential therapeutic agents for cancer treatment.
Research and Clinical Implications
Research on ERKs continues to uncover their roles in different cellular contexts and their potential as targets for therapeutic intervention. Understanding the precise mechanisms of ERK activation and function is crucial for developing effective treatments for diseases associated with ERK dysregulation.
Related Pages
- Mitogen-activated protein kinase
- Cell signaling
- Protein kinase
- Transcription factor
- Cell proliferation
- Cancer
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
